- Previous Close
10.10 - Open
10.10 - Bid 10.12 x --
- Ask 10.69 x --
- Day's Range
10.10 - 10.10 - 52 Week Range
9.43 - 10.69 - Volume
500 - Avg. Volume
1,168 - Market Cap (intraday)
-- - Beta (5Y Monthly) 0.88
- PE Ratio (TTM)
3.09 - EPS (TTM)
3.27 - Earnings Date --
- Forward Dividend & Yield 0.50 (5.09%)
- Ex-Dividend Date Jun 28, 2024
- 1y Target Est
--
Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc. It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada.
www.harvestportfolios.com/closed-end-funds/big-pharma-split-corp/--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: PRM-PA.TO
View More
Performance Overview: PRM-PA.TO
Trailing total returns as of 3/21/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PRM-PA.TO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PRM-PA.TO
View MoreValuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-201.16%
Return on Assets (ttm)
-0.69%
Return on Equity (ttm)
-3.63%
Revenue (ttm)
320.82k
Net Income Avi to Common (ttm)
-645.35k
Diluted EPS (ttm)
3.27
Balance Sheet and Cash Flow
Total Cash (mrq)
204.19k
Total Debt/Equity (mrq)
64.96%
Levered Free Cash Flow (ttm)
4.09M
Company Insights: PRM-PA.TO
PRM-PA.TO does not have Company Insights